These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12671196)

  • 1. Estradiol effects on the growth hormone/insulin-like growth factor-1 axis in amenorrheic athletes.
    Waters DL; Dorin RI; Qualls CR; Ruby BC; Baumgartner RN; Robergs RA
    Can J Appl Physiol; 2003 Feb; 28(1):64-78. PubMed ID: 12671196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased pulsatility, process irregularity, and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes.
    Waters DL; Qualls CR; Dorin R; Veldhuis JD; Baumgartner RN
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1013-9. PubMed ID: 11238479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes.
    Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4301-9. PubMed ID: 8954031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY; Leung KC; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of IGF-I affects the GH axis and adolescent growth in normal monkeys.
    Wilson ME
    J Endocrinol; 1997 May; 153(2):327-35. PubMed ID: 9166124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
    Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
    Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
    Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
    Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate].
    Milewicz T; Krzysiek J; Rogatko I; Sztefko K; Stochmal E; Hubalewska-Dydejczyk A; Jach R; Radowicki S
    Ginekol Pol; 2011 Mar; 82(3):200-4. PubMed ID: 21735688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.